Impact of melanin on microbial virulence and clinical resistance to antimicrobial compounds

Antimicrobial Agents and Chemotherapy

Volumn 50, Issue 11, 2006, Pages 3519-3528

  Nosanchuk, Joshua D ^a   Casadevall, Arturo ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ACID; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTIINFECTIVE AGENT; CASPOFUNGIN; CEPHALOSPORIN DERIVATIVE; CHLOROFORM; CYSTEINE; DIAMORPHINE; ENZYME; EUMELANIN; HEAVY METAL; HERBICIDE; LEVODOPA; MELANIN; OXIDIZING AGENT; PARAQUAT; PENICILLIN DERIVATIVE; PEPTIDE DERIVATIVE; PHENOTHIAZINE DERIVATIVE; PHEOMELANIN; POLYSACCHARIDE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TETRACYCLINE DERIVATIVE; TOBRAMYCIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIFUNGAL ACTIVITY; BACTERIAL SURVIVAL; DRUG EFFICACY; DRUG PROTEIN BINDING; HOST RESISTANCE; HUMAN; INFECTION; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VIRULENCE;

ANTI-BACTERIAL AGENTS; ANTIFUNGAL AGENTS; BACTERIA; CELL WALL; DRUG RESISTANCE, BACTERIAL; DRUG RESISTANCE, FUNGAL; FUNGI; HUMANS; MELANINS; MICROBIAL SENSITIVITY TESTS; POROSITY;

EID: 33750589315     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.00545-06     Document Type: Short Survey

References (153)

1. Abruzzo, G. K., A. M. Flattery, C. J. Gill, L. Kong, J. G. Smith, V. B. Pikounis, J. M. Balkovec, A. F. Boufard, J. F. Dropinski, H. Rosen, H. Kropp, and K. Bartizal. 1997. Evaluation of the echinocandin antifungal MK-0991 (L-743,872): efficacies in mouse models of disseminated aspergillosis, candidiasis, and cryptococcosis. Antimicrob. Agents Chemother. 41:2333-2338.
2. Alviano, D. S., A. J. Franzen, L. R. Travassos, C. Holandino, S. Rozental, R. Ejzemberg, C. S. Alviano, and M. L. Rodrigues. 2004. Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes. Infect. Immun. 72:229-237.
3. + and paraquat in Rana pipiens. Life Sci. 37:1529-1538.
4. Barza, M. 1978. Factors affecting the intraocular penetration of antibiotics. The influence of route, inflammation, animal species and tissue pigmentation. Scand. J. Infect. Dis. Suppl, p. 151-159.
5. Barza, M., J. Baum, and A. Kane. 1976. Inhibition of antibiotic activity in vitro by synthetic melanin. Antimicrob. Agents Chemother. 10:569-570.
6. Bathory, G., T. Szuts, and K. Magyar. 1987. Studies on the melanin affinity of selegiline (deprenyl) and other amphetamine derivatives. Pol. J. Pharmacol. Pharm. 39:195-201.
7. Black, F. O., S. Pesznecker, and V. Stallings. 2004. Permanent gentamicin vestibulotoxicity. Otol. Neurotol. 25:559-569.
8. Blasi, E., R. Barluzzi, R. Mazzolla, B. Tancini, S. Saieppico, M. Puliti, L. Pitzurra, and F. Bistoni. 1995. Role of nitric oxide and melanogenesis in the accomplishment of anticryptococcal activity by the BV-2 microglial cell line. J. Neuroimmunol. 58:111-116.
9. Bloomfield, B. J., and M. Alexander. 1967. Melanins and resistance of fungi to lysis. J. Bacteriol. 93:1276-1280.
10. Bocca, A. L., P. P. Brito, F. Figueiredo, and C. E. Tosta. 2006. Inhibition of nitric oxide production by macrophages in chromoblastomycosis: a role for Fonsecaea pedrosoi melanin. Mycopathologia 161:195-203.
11. Borel, M., D. Lafarge, M. F. Morean, M. Bayle, L. Audin, N. Moins, and J. C. Madelmont. 2005. High resolution magic angle spinning NMR spectroscopy used to investigate the ability of drugs to bind to synthetic melanin. Pigment Cell Res. 18:49-54.
12. Borges, C. R., J. C. Roberts, D. G. Wilkins, and D. E. Rollins. 2003. Cocaine, benzoylecgonine, amphetamine, and N-acetylamphetamine binding to melanin subtypes. J. Anal. Toxicol. 27:125-134.
13. Brandt, M. E., and D. W. Warnock. 2003. Epidemiology, clinical manifestations, and therapy of infections caused by dematiaceous fungi. J. Chemother. 15:36-47.
14. Bridelli, M. G., A. Ciati, and P. R. Crippa. 2006. Binding of chemicals to melanins re-examined: adsorption of some drugs to the surface of melanin particles. Biophys. Chem. 119:137-145.
15. Bull, A. T. 1970. Inhibition of polysaccharases by melanin: enzyme inhibition in relation to mycolysis. Arch. Biochem. Biophys. 137:345-356.
16. Buszman, E., and R. Rozanska. 2003. Interaction of quinidine, disopyramide and metoprolol with melanin in vitro in relation to drug-induced ocular toxicity. Pharmazie 58:507-511.
17. Butler, M. J., and A. W. Day. 1998. Fungal melanins: a review. Can. J. Microbiol. 44:1115-1136.
18. Castanet, J., and J. P. Ortoune. 1997. Hair melanin and hair color. EXS 78:209-225.
19. Conlee, J. W., M. L. Bennett, and D. J. Creel. 1995. Differential effects of gentamicin on the distribution of cochlear function in albino and pigmented guinea pigs. Acta Otolaryngol. 115:367-374.
20. Cunha, M. M., A. J. Franzen, D. S. Alviano, E. Zanardi, C. S. Alviano, W. De Souza, and S. Rozental. 2005. Inhibition of melanin synthesis pathway by tricyclazole increases susceptibility of Fonsecaea pedrosoi against mouse macrophages. Microsc. Res. Tech. 68:377-384.
21. da Silva, M. B., A. F. Marques, J. D. Nosanchuk, A. Casadevall, L. R. Travassos, and C. P. Taborda. 2006. Melanin in the dimorphic fungal pathogen Paracoccidioides brasiliensis: effects on phagocytosis, intracellular resistance and drug susceptibility. Microbes Infect. 8:197-205.
22. Dixon, D. M., J. Migliozzi, C. R. Cooper, Jr., O. Solis, B. Breslin, and P. J. Szaniszlo. 1992. Melanized and non-melanized multicellular form mutants of Wangiella dermatitidis in mice: mortality and histopathology studies. Mycoses 35:17-21.
23. - mutants of Wangiella dermatitidis in mice: evaluation of multiple mouse and fungal strains. J. Med. Vet. Mycol. 27:335-341.
24. Dixon, D. M., A. Polak, and P. J. Szaniszlo. 1987. Pathogenicity and virulence of wild-type and melanin-deficient Wangiella dermatitidis. J. Med. Vet. Mycol. 25:97-106.
25. Dixon, D. M., P. J. Szaniszlo, and A. Polak. 1991. Dihydroxynaphthalene (DHN) melanin and its relationship with virulence in the early stages of phaeohyphomycosis, p. 297-318. In G. Cole and H. Hoch (ed.), The fungal spore and disease initiation in plants and animals. Plenum Press, New York, N.Y.
26. Doering, T. L., J. D. Nosanchuk, W. K. Roberts, and A. Casadevall. 1999. Melanin as a potential cryptococcal defence against microbicidal proteins. Med. Mycol. 37:175-181.
27. Eisenman, H. C., J. D. Nosanchuk, J. B. Webber, R. J. Emerson, T. A. Camesano, and A. Casadevall. 2005. Microstructure of cell wall-associated melanin in the human pathogenic fungus Cryptococcus neoformans. Biochemistry 44:3683-3693.
28. Emery, H. S., C. P. Shelburne, J. P. Bowman, P. G. Fallon, C. A. Schulz, and E. S. Jacobson. 1994. Genetic study of oxygen resistance and melanization in Cryptococcus neoformans. Infect. Immun. 62:5694-5697.
29. Enochs, W. S., M. J. Nilges, and H. M. Swartz. 1993. A standardized test for the identification and characterization of melanins using electron paramagnetic (EPR) spectroscopy. Pigment Cell Res. 6:91-99.
30. Eves, P., L. Smith-Thomas, S. Hedley, M. Wagner, C. Balafa, and S. MacNeil. 1999. A comparative study of the effect of pigment on drug toxicity in human choroidal melanocytes and retinal pigment epithelial cells. Pigment Cell Res. 12:22-35.
31. Feldmesser, M., Y. Kress, and A. Casadevall. 2001. Dynamic changes in the morphology of Cryptococcus neoformans during murine pulmonary infection. Microbiology 147:2355-2365.
32. Feldmesser, M., Y. Kress, A. Mednick, and A. Casadevall. 2000. The effect of the echinocandin analogue caspofungin on cell wall glucan synthesis by Cryptococcus neoformans. J. Infect. Dis. 182:1791-1795.
33. Feng, B., X. Wang, M. Hauser, S. Kaufmann, S. Jentsch, G. Haase, J. M. Becker, and P. J. Szaniszlo. 2001. Molecular cloning and characterization of WdPKS1, a gene involved in dihydroxynaphthalene melanin biosynthesis and virulence in Wangiella (Exophiala) dermatitidis. Infect. Immun. 69:1781-1794.
34. Fiore, G., A. Poli, A. Di Cosmo, M. d'Ischia, and A. Palumbo. 2004. Dopamine in the ink defense system of Sepia officinalis: biosynthesis, vesicular compartmentation in mature ink gland cells, nitric oxide (NO)/cGMP-induced depletion and fate in secreted ink. Biochem. J. 378:785-791.
35. Fogarty, R. V., and J. M. Tobin. 1996. Fungal melanins and their interactions with metals. Enzyme Microb. Technol. 19:311-317.
36. Franzot, S. P., and A. Casadevall. 1997. Pneumocandin L-743,872 enhances the activities of amphotericin B and fluconazole against Cryptococcus neoformans in vitro. Antimicrob. Agents Chemother. 41:331-336.
37. Fukuda, M., Y. Morita, K. Sasaki, and Y. Yamamoto. 2000. Studies on the binding mechanism of fluoroquinolones to melanin. J. Infect. Chemother. 6:72-76.
38. Fukuda, M., and K. Sasaki. 1990. Changes in the antibacterial activity of melanin-bound drugs. Ophthalmic Res. 22:123-127.
39. Fukuda, M., and K. Sasaki. 1995. Differences between albino and pigmented rabbit eyes in the intraocular pharmacokinetics of sparfloxacin. Drugs 49:314-316.
40. Fukuda, M., and K. Sasaki. 1994. Different iris coloration and uptake of a fluoroquinolone agent into the iris ciliary body of rabbit eyes. Ophthalmic Res. 26:137-140.
41. Gan, E. V., H. F. Haberman, and I. A. Menon. 1976. Electron transfer properties of melanin. Arch. Biochem. Biophys. 173:666-672.
42. Garcia-Rivera, J., and A. Casadevall. 2001. Melanization of Cryptococcus neoformans reduces its susceptibility to the antimicrobial effects of silver nitrate. Med. Mycol. 39:353-357.
43. Gautam, L., K. S. Scott, and M. D. Cole. 2005. Amphetamine binding to synthetic melanin and Scatchard analysis of binding data. J. Anal. Toxicol. 29:339-344.
44. Hart, C. W., and R. F. Naunton. 1964. The ototoxicity of chloroquine phosphate. Arch. Otolaryngol. 80:407-412.
45. Henson, J. M., M. J. Butler, and A. W. Day. 1999. The dark side of the mycelium: melanins of phytopathogenic fungi. Annu. Rev. Phytopathol. 37:447-471.
46. Herrero, M. T., E. C. Hirsch, A. Kastner, M. Ruberg, M. R. Luquin, J. Laguna, F. Javoy-Agid, J. A. Obeso, and Y. Agid. 1993. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP? Neuroscience 56:499-511.
47. Hill, H. Z. 1991. Melanins in the photobiology of skin cancer and the radiobiology of melanomas, p. 31-53. In S. H. Wilson (ed.), Cancer biology and biosynthesis. Telford Press, Caldwell, N.J.
48. Hill, H. Z. 1992. The function of melanin or six blind people examine an elephant. Bioessays 14:49-56.
49. Hobbs, H. E., A. Sorsby, and A. Freedman. 1959. Retinopathy following chloroquine therapy. Lancet ii:478-480.
50. Huffnagle, G. B., G. H. Chen, J. L. Curtis, R. A. McDonald, R. M. Strieter, and G. B. Toews. 1995. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. J. Immunol. 155:3507-3516.
51. Icenhour, C. R., T. J. Kottom, and A. H. Limper. 2006. Pneumocystis melanins confer enhanced organism viability. Eukaryot. Cell 5:916-923.
52. Ikeda, R., T. Sugita, E. S. Jacobson, and T. Shinoda. 2003. Effects of melanin upon susceptibility of Cryptococcus to antifungals. Microbiol. Immunol. 47:271-277.
53. Ings, R. 1984. The melanin binding of drugs and its implications. Drug Metab. Rev. 15:1183-1212.
54. Jacobson, E. S. 2000. Pathogenic roles for fungal melanins. Clin. Microbiol. Rev. 13:708-717.
55. Jacobson, E. S., and H. S. Emery. 1991. Catecholamine uptake, melanization, and oxygen toxicity in Cryptococcus neoformans. J. Bacteriol. 173:401-403.
56. Jacobson, E. S., and J. D. Hong. 1997. Redox buffering by melanin and Fe(II) in Cryptococcus neoformans. J. Bacteriol. 179:5340-5346.
57. Jacobson, E. S., and R. Ikeda. 2005. Effect of melanization upon porosity of the cryptococcal cell wall. Med. Mycol. 43:327-333.
58. Jacobson, E. S., N. D. Jenkins, and J. M. Todd. 1994. Relationship between superoxide dismutase and melanin in a pathogenic fungus. Infect. Immun. 62:4085-4086.
59. Jacobson, E. S., and S. B. Tinnell. 1993. Antioxidant function of fungal melanin. J. Bacteriol. 175:7102-7104.
60. Jahn, B., A. Koch, A. Schmidt, G. Wanner, H. Gehringer, S. Bhakdi, and A. A. Brakhage. 1997. Isolation and characterization of a pigmentless-conidium mutant of Aspergillus fumigatus with altered conidial surface and reduced virulence. Infect. Immun. 65:5110-5117.
61. Joseph, R. E., Jr., W. J. Tsai, L. I. Tsao, T. P. Su, and E. J. Cone. 1997. In vitro characterization of cocaine binding sites in human hair. J. Pharmacol. Exp. Ther. 282:1228-1241.
62. Kaliszan, R., A. Kaliszan, and I. W. Wainer. 1993. Prediction of drug binding to melanin using a melanin-based high-performance liquid chromatographic stationary phase and chemometric analysis of the chromatographic data. J. Chromatogr. 615:281-288.
63. Kane, A., M. Barza, and J. Baum. 1981. Intravitreal injection of gentamicin in rabbits. Effect of inflammation and pigmentation on half-life and ocular distribution. Investig. Ophthalmol. Vis. Sci. 20:593-597.
64. Kawamura, C., T. Tsujimoto, and T. Tsuge. 1999. Targeted disruption of a melanin biosynthesis gene affects conidial development and UV tolerance in the Japanese pear pathotype of Alternaria alternata. Mol. Plant-Microbe Interact. 12:59-63.
65. Keithley, E. M., A. F. Ryan, and M. L. Feldman. 1992. Cochlear degeneration in aged rats of four strains. Hear. Res. 59:171-178.
66. Kumana, C. R., and K. Y. Yuen. 1994. Parenteral aminoglycoside therapy. Selection, administration and monitoring. Drugs 47:902-913.
67. Kuo, M. J., and M. Alexander. 1967. Inhibition of the lysis of fungi by melanins. J. Bacteriol. 94:624-629.
68. Lamy-Freund, M. T., S. Schreier, R. M. Peitzsch, and W. F. Reed. 1991. Characterization and time dependence of amphotericin B: deoxycholate aggregation by quasielastic light scattering. J. Pharm. Sci. 80:262-266.
69. Larsson, B., and H. Tjalve. 1979. Studies on the mechanism of drug-binding to melanin. Biochem. Pharmacol. 28:1181-1187.
70. Larsson, B. S. 1993. Interaction between chemicals and melanin. Pigment Cell Res. 6:127-133.
71. Larsson, B. S. 1991. Melanin-affinic thioureas as selective melanoma seekers. Melanoma Res. 1:85-90.
72. Lin, W. P., H. L. Lai, Y. L. Liu, Y. M. Chiung, C. Y. Shiau, J. M. Han, C. M. Yang, and Y. T. Liu. 2005. Effect of melanin produced by a recombinant Escherichia coli on antibacterial activity of antibiotics. J. Microbiol. Immunol. Infect. 38:320-326.
73. 35S- chlorpromazine in the neuromelanin of human substantia nigra and locus coeruleus. Arch. Int. Pharmacodyn. Ther. 200:190-195.
74. Lindquist, N. G. 1973. Accumulation of drugs on melanin. Acta Radiol. Diagn. (Stockholm) 325:1-92.
75. Liu, G. Y., A. Essex, J. T. Buchanan, V. Datta, H. M. Hoffman, J. F. Bastian, J. Fierer, and V. Nizet. 2005. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202:209-215.
76. Liu, L., R. P. Tewari, and P. R. Williamson. 1999. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages. Infect. Immun. 67:6034-6039.
77. Lukiewicz, S., K. Reszka, and Z. Matusak. 1980. Simultaneous electochemical-electron spin resonance (SEESR) studies on natural and synthetic melanins. Bioelectrochem. Bioenerg. 7:153-165.
78. Marmaras, V. J., N. D. Charalambidis, and C. G. Zervas. 1996. Immune response in insects: the role of phenoloxidase in defense reactions in relation to melanization and sclerotization. Arch. Insect Biochem. Physiol. 31:119-133.
79. Mars, U., and B. S. Larsson. 1999. Pheomelanin as a binding site for drugs and chemicals. Pigment Cell Res. 12:266-274.
80. Martinez, L. R., and A. Casadevall. 2006. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro. Antimicrob. Agents Chemother. 50:1021-1033.
81. McGinnis, M. R., and L. Pasarell. 1998. In vitro testing of susceptibilities of filamentous ascomycetes to voriconazole, itraconazole, and amphotericin B, with consideration of phylogenetic implications. J. Clin. Microbiol. 36:2353-2355.
82. Mednick, A. J., J. D. Nosanchuk, and A. Casadevall. 2005. Melanization of Cryptococcus neoformans affects lung inflammatory responses during cryptococcal infection. Infect. Immun. 73:2012-2019.
83. Mironenko, N. V., I. A. Alekhina, N. N. Zhdanova, and S. A. Bulat. 2000. Intraspecific variation in gamma-radiation resistance and genomic structure in the filamentous fungus Alternaria alternata: a case study of strains inhabiting Chernobyl Reactor No. 4. Ecotoxicol. Environ. Safety 45:177-187.
84. Mylonakis, E., F. M. Ausubel, J. R. Perfect, J. Heitman, and S. B. Calderwood. 2002. Killing of Caenorhabditis elegans by Cryptococcus neoformans as a model of yeast pathogenesis. Proc. Natl. Acad. Sci. USA 99:15675-15680.
85. Nappi, A. J., and B. M. Christensen. 2005. Melanogenesis and associated cytotoxic reactions: applications to insect innate immunity. Insect Biochem. Mol. Biol. 35:443-459.
86. National Committee for Clinical Laboratory Standards. 2002. Reference method for broth dilution antifungal susceptibility testing of conidium-forming filamentous fungi. Approved standard M38-A. National Committee for Clinical Laboratory Standards, Wayne, Pa.
87. Nicholaus, R., M. Piatelli, and E. Fattorusso. 1964. The structure of melanins and melanogenesis. IV. On some natural melanins. Tetrahedron 20:1163-1172.
88. Nosanchuk, J., and A. Casadevall. 1997. Cellular charge of Cryptococcus neoformans: contributions from the capsular polysaccharide, melanin, and monoclonal antibody binding. Infect. Immun. 65:1836-1841.
89. Nosanchuk, J. D., and A. Casadevall. 2003. Budding of melanized Cryptococcus neoformans in the presence or absence of L-dopa. Microbiology 149:1945-1951.
90. Nosanchuk, J. D., and A. Casadevall. 2003. The contribution of melanin to microbial pathogenesis. Cell. Microbiol. 5:203-223.
91. Nosanchuk, J. D., A. Casadevall, and R. Ovalle. January 2003. Method for inhibiting melanogenesis and uses thereof. U.S. patent 6,509,325.
92. Nosanchuk, J. D., R. Ovalle, and A. Casadevall. 2001. Glyphosate inhibits melanization of Cryptococcus neoformans and prolongs survival of mice after systemic infection. J. Infect. Dis. 183:1093-1099.
93. Nosanchuk, J. D., A. L. Rosas, S. C. Lee, and A. Casadevall. 2000. Melanisation of Cryptococcus neoformans in human brain tissue. Lancet 355:2049-2050.
94. Nosanchuk, J. D., J. Rudolph, A. L. Rosas, and A. Casadevall. 1999. Evidence that Cryptococcus neoformans is melanized in pigeon excreta: implications for pathogenesis. Infect. Immun. 67:5477-5479.
95. Nosanchuk, J. D., P. Valadon, M. Feldmesser, and A. Casadevall. 1999. Melanization of Cryptococcus neoformans in murine infection. Mol. Cell. Biol. 19:745-750.
96. Nosanchuk, J. D., D. van Duin, P. Mandal, P. Aisen, A. M. Legendre, and A. Casadevall. 2004. Blastomyces dermatitidis produces melanin in vitro and during infection. FEMS Microbiol. Lett. 239:187-193.
97. Nyhus, K. J., A. T. Wilborn, and E. S. Jacobson. 1997. Ferric iron reduction by Cryptococcus neoformans. Infect. Immun. 65:434-438.
98. Patel, K., J. Wyman, K. Patel, and B. Burden. 1996. A mutant of Bacillus thuringiensis producing a dark-brown pigment with increased UV resistance and insecticidal activity. J. Invertebr. Pathol. 67:120-124.
99. Peltroche-Llacsahuanga, H., N. Schnitzler, S. Jentsch, A. Platz, S. De Hoog, K. G. Schweizer, and G. Haase. 2003. Analyses of phagocytosis, evoked oxidative burst, and killing of black yeasts by human neutrophils: a tool for estimating their pathogenicity? Med. Mycol. 41:7-14.
100. Perfect, J. R., K. A. Marr, T. J. Walsh, R. N. Greenberg, B. DuPont, J. de la Torre-Cisneros, G. Just-Nubling, H. T. Schlamm, I. Lutsar, A. Espinel-Ingroff, and E. Johnson. 2003. Voriconazole treatment for less-common, emerging, or refractory fungal infections. Clin. Infect. Dis. 36:1122-1131.
101. Polak, A., and D. M. Dixon. 1989. Loss of melanin in Wangiella dermatitidis does not result in greater susceptibility to antifungal agents. Antimicrob. Agents Chemother. 33:1639-1640.
102. 3H-cocaine binding on melanin granules and human hair in vitro. Int. J. Legal Med. 110:55-62.
103. Prota, G. 1992. Melanins and melanogenesis. Academic Press, Inc., San Diego, Calif.
104. Richman, A., and F. C. Kafatos. 1996. Immunity to eukaryotic parasites in vector insects. Curr. Opin. Immunol. 8:14-19.
105. Rizzo, D., R. Blanchette, and M. Palmer. 1992. Biosorption of metal ions by Armillaria rhizomorphus. Can. J. Bot. Rev. 70:1515-1520.
106. Roberto, A., B. S. Larsson, and H. Tjalve. 1996. Uptake of 7,12-dimethylbenz(a)anthracene and benzo(a)pyrene in melanin-containing tissues. Pharmacol. Toxicol. 79:92-99.
107. Romero-Martinez, R., M. Wheeler, A. Guerrero-Plata, G. Rico, and H. Torres-Guerrero. 2000. Biosynthesis and functions of melanin in Sporothrix schenckii. Infect. Immun. 68:3696-3703.
108. Rosas, A. L., and A. Casadevall. 1997. Melanization affects susceptibility of Cryptococcus neoformans to heat and cold. FEMS Microbiol. Lett. 153:265-272.
109. Rosas, A. L., and A. Casadevall. 2001. Melanization decreases the susceptibility of Cryptococcus neoformans to enzymatic degradation. Mycopathologia 151:53-56.
110. Rosas, A. L., J. D. Nosanchuk, and A. Casadevall. 2001. Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection. Infect. Immun. 69:3410-3412.
111. Rozhavin, M. A. 1978. Effect of Pseudomonas aeruginosa melanin on antibiotic activity. Antibiotiki 23:718-720.
112. Rozhavin, M. A., and V. V. Sologub. 1979. Comparison of the sensitivity of Pseudomonas aeruginosa cultures that synthesize melanin and other pigments to 12 antibiotics and 5-nitro-8-quinolinol. Antibiotiki 24:921-922.
113. Saleh, Y. G., M. S. Mayo, and D. G. Ahearn. 1988. Resistance of some common fungi to gamma irradiation. Appl. Environ. Microbiol. 54:2134-2135.
114. Sanchez-Ferrer, A., J. N. Rodriguez-Lopez, F. Garcia-Canovas, and F. Garcia-Carmona. 1995. Tyrosinase: a comprehensive review of its mechanism. Biochim. Biophys. Acta 1247:1-11.
115. Schnitzler, N., H. Peltroche-Llacsahuanga, N. Bestier, J. Zundorf, R. Lutticken, and G. Haase. 1999. Effect of melanin and carotenoids of Exophiala (Wangiella) dermatitidis on phagocytosis, oxidative burst, and killing by human neutrophils. Infect. Immun. 67:94-101.
116. 2- ·. Free Radic. Biol. Med. 11:1-8.
117. Steenbergen, J. N., and A. Casadevall. 2003. The origin and maintenance of virulence for the human pathogenic fungus Cryptococcus neoformans. Microbes Infect. 5:667-675.
118. Steenbergen, J. N., H. A. Shuman, and A. Casadevall. 2001. Cryptococcus neoformans interactions with amoebae suggest an explanation for its virulence and intracellular pathogenic strategy in macrophages. Proc. Natl. Acad. Sci. USA 98:15245-15250.
119. 3H]flunitrazepam in mouse hair melanosomes after systemic administration. Drug Metab. Dispos. 27:731-735.
120. Surazynski, A., J. Palka, D. Wrzesniok, E. Buszman, and P. Kaczmarczyk. 2001. Melanin potentiates daunorubicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Eur. J. Pharmacol. 419:139-145.
121. Svensson, S. P., S. Lindgren, W. Powell, and H. Green. 2003. Melanin inhibits cytotoxic effects of doxorubicin and daunorubicin in MOLT 4 cells. Pigment Cell Res. 16:351-354.
122. 14C-spermidine to melanin in vivo and in vitro. Acta Physiol. Scand. 112:209-214.
123. Tjalve, H., M. Nilsson, and B. Larsson. 1981. Studies on the binding of chlorpromazine and chloroquine to melanin in vivo. Biochem. Pharmacol. 30:1845-1847.
124. Van Duin, D., A. Casadevall, and J. D. Nosanchuk. 2002. Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces thier susceptibility to amphotericin B and caspofungin. Antimicrob. Agents Chemother. 46:3394-3400.
125. Van Duin, D., W. Cleare, O. Zaragoza, A. Casadevall, and J. D. Nosanchuk. 2004. Effects of voriconazole on Cryptococcus neoformans. Antimicrob. Agents Chemother. 48:2014-2020.
126. Varanasi, N. L., I. Baskaran, G. J. Alangaden, P. H. Chandrasekar, and E. K. Manavathu. 2004. Novel effect of voriconazole on conidiation of Aspergillus species. Int. J. Antimicrob. Agents 23:72-79.
127. Vasilevskaya, A., N. M. Zhdanova, and V. D. Pokhodenko. 1970. Character of survival of some gamma irradiated species of dark-colored Hyphomycetes. Mikrobiol. Zh. 33:438-441.
128. Wakamatsu, K., and S. Ito. 2002. Advanced chemical methods in melanin determination. Pigment Cell Res. 15:174-183.
129. Wakamatsu, K., S. Ito, and J. L. Rees. 2002. The usefulness of 4-amino-3-hydroxyphenylalanine as a specific marker of pheomelanin. Pigment Cell Res. 15:225-232.
130. Wang, Y., P. Aisen, and A. Casadevall. 1995. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect. Immun. 63:3131-3136.
131. Wang, Y., P. Aisen, and A. Casadevall. 1996. Melanin, melanin "ghosts," and melanin composition in Cryptococcus neoformans. Infect. Immun. 64:2420-2424.
132. Wang, Y., and A. Casadevall. 1994. Decreased susceptibility of melanized Cryptoccocus neoformans to the fungicidal effects of ultraviolet light. Appl. Environ. Microbiol. 60:3864-3866.
133. Wang, Y., and A. Casadevall. 1994. Growth of Cryptococcus neoformans in presence of L-dopa decreases its susceptibility to amphotericin B. Antimicrob. Agents Chemother. 38:2648-2650.
134. Wang, Y., and A. Casadevall. 1994. Susceptibility of melanized and non-melanized Cryptococcus neoformans to nitrogen- and oxygen-derived oxidants. Infect. Immun. 62:3004-3007.
135. Wang, Y., and A. Casadevall. 1996. Susceptibility of melanized and non-melanized Cryptococcus neoformans to the melanin-binding compounds trifluoperazine and chloroquine. Antimicrob. Agents Chemother. 40:541-545.
136. Wasterstrom, S. A. 1984. Accumulation of drugs on inner ear melanin. Therapeutic and ototoxic mechanisms. Scand. Audiol. Suppl. 23:1-40.
137. Wasterstrom, S. A., and G. Bredberg. 1986. Ototoxicity of kanamycin in albino and pigmented guinea pigs. II. A scanning electron microscopic study. Am. J. Otol. 7:19-24.
138. Wheeler, M. H., and A. A. Bell. 1988. Melanins and their importance in pathogenic fungi. Curr. Top. Med. Mycol. 2:338-387.
139. White, L. P. 1958. Melanin: a naturally occurring cation exchange material. Nature 182:1427-1428.
140. Wilkins, D. G., A. Mizuno, C. R. Borges, M. H. Slawson, and D. E. Rollins. 2003. Ofloxacin as a reference marker in hair of various colors. J. Anal. Toxicol. 27:149-155.
141. Wrzesniok, D., E. Buszman, E. Karna, P. Nawrat, and J. Palka. 2002. Melanin potentiates gentamicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Eur. J. Pharmacol. 446:7-13.
142. Wrzesniok, D., E. Buszman, E. Karna, and J. Palka. 2005. Melanin potentiates kanamycin-induced inhibition of collagen biosynthesis in human skin fibroblasts. Pharmazie 60:439-443.
143. Wu, W. J., S. H. Sha, J. D. McLaren, K. Kawamoto, Y. Raphael, and J. Schacht. 2001. Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. Hear. Res. 158:165-178.
144. Yabuuchi, E., and A. Ohyama. 1972. Characterization of pyomelanin-producing strains of Pseudomonas aeruginosa. Int. J. Syst. Bacteriol. 22:53-64.
145. Yang, Z., R. C. Pascon, A. Alspaugh, G. M. Cox, and J. H. McCusker. 2002. Molecular and genetic analysis of the Cryptococcus neoformans MET3 gene and a met3 mutant. Microbiology 148:2617-2625.
146. Youngchim, S., R. Morris-Jones, R. J. Hay, and A. J. Hamilton. 2004. Production of melanin by Aspergillus fumigatus. J. Med. Microbiol. 53:175-181.
147. Zecca, L., D. Tampellini, A. Gatti, R. Crippa, M. Eisner, D. Sulzer, S. Ito, R. Fariello, and M. Gallorini. 2002. The neuromelanin of human substantia nigra and its interaction with metals. J. Neural Transm. 109:663-672.
148. Zecca, L., D. Tampellini, M. Gerlach, P. Riederer, R. G. Fariello, and D. Sulzer. 2001. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Mol. Pathol. 54;414-418.
149. Zhdanova, N. N., A. I. Gavriushina, and A. I. Vasilevskaia. 1973. Effect of gamma and UV irradiation on the survival of Cladosporium sp. and Oidiodendron cerealis. Mikrobiol. Zh. 35:449-452.
150. Zhdanova, N. N., and V. D. Pokhodenko. 1974. The protective properties of fungal melanin pigment in some soil Dematiaceae. Radiat. Res. 59:221.
151. Zinn, K. M., and D. Z. Greenseid. 1975. Toxicology of the retinal pigment epithelium. Int. Ophthalmol. Clin. 15:147-158.
152. Zuger, A., E. Louie, R. S. Holzman, M. S. Simberkoff, and J. J. Rahal. 1986. Cryptococcal disease in patients with the acquired immunodeficiency syndrome: diagnostic features and outcome of treatment. Ann. Intern. Med. 104:234-240.
153. Zunino, H., and J. Martin. 1977. Metal-binding organic molecules in soil. 1. Hypothesis interpreting the role of soil organic matter in the translocation of metals ions from rocks to the biological system. Soil Sci. 123:65-76.